纵横研报
Ticker Detail

601607.SHG

¥16.87+1.57% 上海医药 Medical Distribution
00Reports China 医疗健康
Shanghai Pharmaceuticals Holding Co Ltd
医疗健康 · 医药分销

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

MARKET 市值 60.63B CNY PE 10.5x Fwd 16.8x 52W ¥15.01 – ¥19.68 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 9.24 营收 YoY 6.4% ROE 8.1% 营业利润率 3.5% 净利润率 2.0%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制